Despite numerous evidence confirming HIF-1α as a risk factor in AD, intricately linked to key mechanisms such as Aβ aggregation, tau phosphorylation, neuroinflammation, some studies suggest that HIF-1α may exhibit a protective role in the onset of AD. This evidence concerns the gene MAPT and Alzheimer disease.